Cardinal Health, Inc. $CAH Stock Purchased by Asset Management One Co. Ltd.

Key Points

• Asset Management One increased its Cardinal Health stake by 6.4% in the third quarter, bringing its holdings to 127,699 shares valued at approximately $28.4 million. Institutional investors collectively own 87.17% of the company.
• Cardinal Health reported quarterly EPS of $2.91, exceeding estimates of $2.42, while revenue rose 5.8% year over year to $63.67 billion. The company maintained fiscal 2027 EPS guidance of $12.40–$12.60.
• Analyst sentiment remains positive, with a “Moderate Buy” consensus and an average price target of $269.38; however, insiders have sold 210,271 shares worth about $49.6 million over the past 90 days.

Asset Management One Co. Ltd. boosted its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 127,699 shares of the company's stock after purchasing an additional 7,696 shares during the period. Asset Management One Co. Ltd. owned about 0.06% of Cardinal Health worth $28,413,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CAH. BlackRock Inc. acquired a new stake in shares of Cardinal Health in the second quarter valued at $6,293,115,000. Wellington Management Group LLP boosted its holdings in Cardinal Health by 247.5% in the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company's stock valued at $3,530,206,000 after purchasing an additional 10,584,119 shares during the period. Bank of America Corp DE acquired a new position in Cardinal Health during the 2nd quarter worth $689,066,000. Legal & General Group Plc acquired a new position in Cardinal Health during the 2nd quarter worth $438,870,000. Finally, Pacer Advisors Inc. increased its holdings in Cardinal Health by 14.7% during the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company's stock worth $330,728,000 after purchasing an additional 200,021 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 2.7%

Shares of Cardinal Health stock opened at $251.40 on Friday. Cardinal Health, Inc. has a 52 week low of $180.45 and a 52 week high of $259.21. The firm's 50 day moving average is $237.31 and its two-hundred day moving average is $222.05. The firm has a market capitalization of $58.21 billion, a P/E ratio of 34.77, a P/E/G ratio of 1.47 and a beta of 0.50.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. During the same quarter in the previous year, the firm earned $2.08 EPS. The company's revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 1st were issued a dividend of $0.5158 per share. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. Cardinal Health's dividend payout ratio (DPR) is currently 28.49%.

Insider Activity

In other Cardinal Health news, CEO Stephen M. Mason sold 35,000 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the completion of the sale, the chief executive officer directly owned 18,061 shares of the company's stock, valued at approximately $4,269,620.40. This trade represents a 65.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michelle D. Greene sold 11,650 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total value of $2,746,138.00. Following the completion of the transaction, the insider owned 10,330 shares in the company, valued at $2,434,987.60. This trade represents a 53.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 210,271 shares of company stock valued at $49,626,657. Insiders own 0.12% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Evercore reiterated an "outperform" rating and issued a $270.00 price objective on shares of Cardinal Health in a research note on Wednesday, August 12th. Robert W. Baird boosted their price objective on Cardinal Health from $251.00 to $274.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 12th. Bank of America upped their target price on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a "buy" rating in a research note on Thursday, July 2nd. Weiss Ratings raised shares of Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a report on Thursday, October 8th. Finally, Citigroup lifted their price target on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a "buy" rating in a research note on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and an average price target of $269.38.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.